Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs
- 1 March 2010
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 70 (5) , 605-621
- https://doi.org/10.2165/10898530-000000000-00000
Abstract
Background: The automatic substitution of bioequivalent generics for brand-name antiepileptic drugs (AEDs) has been linked by anecdotal reports to loss of seizure control. Objective: To evaluate...Keywords
This publication has 40 references indexed in Scilit:
- Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular DiseaseJAMA, 2008
- BIO-AVAILABILITY AND DISSOLUTION OF THREE PHENYTOIN PREPARATIONS FOR CHILDRENDevelopmental Medicine and Child Neurology, 2008
- Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsyClinical Therapeutics, 2007
- Extensions Of Intellectual Property Rights And Delayed Adoption Of Generic Drugs: Effects On Medicaid SpendingHealth Affairs, 2006
- EpilepsyNew England Journal of Medicine, 2001
- Effects of Switching From Depakene to Generic Valproic Acid on Individuals With Mental RetardationMental Retardation, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Bioavailability and dissolution of proprietary and generic formulations of phenytoin.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Comparison of Steady‐State Blood Levels of Two Carbamazepine FormulationsEpilepsia, 1989
- Generic Drug Substitution RevisitedNew England Journal of Medicine, 1987